TargEDys, a French biotech company founded in 2011, specializes in developing precision probiotics called PreciBiomic solutions. Their innovative approach involves using microbiota to control appetite by leveraging bacterial, hormonal mimetic proteins found naturally in the gut microbiome. By translating fundamental research from renowned French institutes into applied research in probiotics, TargEDys aims to improve the quality of life through appetite regulation, nutritional optimization, and mental wellness. Their mission is to address global public health challenges by harnessing the potential of the microbiome and bringing it to the forefront of healthcare.